TCT 268: Index of Suspicion: Predictors of Tricuspid Regurgitation progression and Follow-up Echo imaging- An Artificial-intelligence enhanced study
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Consultant Fee/Honoraria/Speaker's Bureau - Edwards Lifesciences; Boston Scientific Corporation